SUMMARY The rational search of novel bioactive molecules against pathogens with immunomodulatory activity is presently one of the most significant approaches to discover and design new therapeutic agents for effective control of infectious diseases, such as the infection caused by Leishmania parasites. In the present study, we evaluated the therapeutic efficacy of the recently characterized immunomodulatory compound 11 α ,19 β -dihydroxy-7-acetoxy-7-deoxoichangin, a seco -limonoid derived from the bark of Raputia heptaphylla (Pittier) using: (1) peritoneal macrophages and (2) Mesocricetus auratus hamsters infected with Leishmania ( V. ) panamensis and Leishmania ( L. ) amazonensis . We observed the ability of this seco -limonoid to induce the effective control of the parasite either in vitro [determining an effective concentration 50 (EC 50 ) of 59 µ m at the infection model] and in vivo (inducing clinical improvement or even cure in infected animals treated compared with the groups of animals treated with vehicle solution or meglumine antimoniate).